Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2011-07-19
2011-07-19
Peng, Bo (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S184100, C424S185100, C424S204100, C424S221100, C424S093100, C435S325000, C530S403000
Reexamination Certificate
active
07981427
ABSTRACT:
A canine respiratory coronavirus (CRCV) that is present in the respiratory tract of dogs with canine infectious respiratory disease and which has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (e.g., Quebec and LY138) and human coronavirus strain OC43.
REFERENCES:
patent: 5672350 (1997-09-01), Parker et al.
patent: 5750112 (1998-05-01), Gill
patent: 5916570 (1999-06-01), Kapil
patent: 6057436 (2000-05-01), Miller et al.
patent: 6280974 (2001-08-01), Miller et al.
patent: 6372224 (2002-04-01), Miller et al.
patent: 0510773 (1992-10-01), None
patent: WO 93/23423 (1992-11-01), None
patent: WO 98/16643 (1998-04-01), None
patent: WO 99/25838 (1999-05-01), None
American Veterinary Medical Association online publication, “Frequently asked questions about canine respiratory coronavirus” Apr. 2008, accessed from http://www.avma.org/animal—health/canine—coronavirus—faq.asp on Dec. 1, 2008.
Decaro, N. and Buonavoglia, C. 2008 “An update on canine Coronaviruses: virul evolution and pathobiology”Veterinary Medicine132:221-234.
Erles, K. and Brownlie, J 2008 “Canine respiratory coronavirus: An emerging pathogen in the canine infectious respiratory disease complex” Vet Clin Small Anim 38:815-825.
Zhang, X. et al. “Comparison of the nucleotide and deduced amino acid sequences of the S genes specified by virulent and avirulent strains of bovine Coronaviruses”Virology183:397-404, 1991.
Appel and Binn 1987 in “Virus infections of carnivores”, Appel, Ed., 1stEdition, pp. 201-211, Elsevier Science Publishers, Amsterdam.
Balaguer et al. 1991 “Quantification of DNA sequences obtained by polymerase chain reaction using a bioluminescent adsorbent”Anal Biochem195:105-110.
Becker and Guarente 1991 “High-efficiency transformation of yeast by electroporation”Methods Enzymol194:182-187.
Beggs 1978 “Transformation of yeast by replicating hybrid plasmid”Nature275:104-109.
Bemis et al. 1977 “Naturally occuring respiratory disease in a kennel caused byBordetella bronchiseptica” Cornell Vet67:282-293.
Better et al. 1988 “Escherichia colisecretion of an active chimeric antibody fragment”Science240:1041-1047.
Binn et al. 1967 “Viruses recovererd from laboratory dogs with respiratory disease”Proc Soc Exp Biol Med126:140-145.
Binn et al. 1979 “Studies of respiratory disease in random-source laboratory dogs: viral infections in unconditioned dogs”Lab Anim Sci29:48-52.
Bird et al. 1988 “Single chain antigen-binding proteins”Science242:423-426.
Cavanagh et al., pp. 407-411, in “Virus Taxonomy, 6th Report of the International Committee on Taxonomy of Viruses”, Murphy et al., Eds., Springer-Verlag Wein, New York.
Chivers et al. 2001 “The effects of coronavirus on human nasal ciliated respiratory epithelium”Eur Respir J18:965-970.
Cohen et al. 1972 “Nonchromosomal antibiotic resistance in bacteria: Genetic transformation ofEscherichia coliby R-Factor DNA”Proc Natl Acad Sci USA69:2110-2114.
Compton 1991 “Nucleic acid sequence-based amplification”Nature350:91-92.
Coyne and May 1995 “Consideration in using a canine coronavirus vaccine” published as Pfizer Technical Bulletin on the world-wide web at: Pfizer.com/ah/vet/tref/trbull/ccv.html.
DiCesare et al. 1993 “A high-sensitivity electrochemiluminescence-based detection system for automated PCR product quantitation”BioTechniques15:152-157.
Ditchfield et al. 1962 “Association of a canine adenovirus (Toronto A 26/61) with an outbreak of laryngotracheitis (“Kennel cough”)”Can Vet Jour3:238-247.
Erles et al. 2003 “Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease”Virology310:216-223.
Examination Report dated Jul. 17, 2007 corresponding to New Zealand Patent Application No. NZ 556442.
Felsenstein 1989 Phylip-Phylogeny Inference Package (Version 3.2c),Cladistics5:164-166.
GCG Version 10.3: Section of the Program Manual for the GCG Package, Version 10.3, relating to the GAP alignment (1982-2002), Genetics Computer Group, 575 Science Drive, Madison, Wisconsin US 53711.
GenBank Accession No. AF058942 (2000).
GenBank Accession No. AAM77000 (2005).
GenBank Accession No. AF124985 (1999).
GenBank Accession No. AF124986 (1999).
GenBank Accession No. AF124989 (1999).
GenBank Accession No. AF220295 (2003).
GenBank Accession No. AF481863 (2002).
GenBank Accession No. L07747 (2001).
GenBank Accession No. L14643 (2002).
GenBank Accession No. M76373 (2002).
GenBank Accession No. M84486 (1993).
GenBank Accession No. Z32768 (2002).
GenBank Accession No. AF058944 (2000).
GenBank Accession No. AAF25519, 2000.
GenBank Accession No. AF058944, 2000.
GenBank Accession No. P25191, 2008.
GenBank Accession No. P25194, 2008.
GenBank Accession No. S44240, 1999.
Grand Laboratories Inc. Technical Information on Scour Bos TM 4. On the world-wide-web at grandlab.com/bioproducts (2000).
Hawoksuz et al. (1999) “Antigenic variation among bovine enteric Coronaviruses (BECV) and bovine respiratory coronaviruses (BRCV) detected using monoclonal antibodies”Archives of Virology144:2441-2447.
Houston et al. 1988 “Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced inEscherichia coli” Proc Natl Acad Sci USA85:5879-5883.
Iacobelli et al. 1988 “Measurement of a breast cancer associated antigen detected by monoclonal antibody SP-2 in sera of cancer patients”Breast Cancer Research and Treatment11:19-30.
Ignjatovic and Sapats 2000 “Avian infectious bronchitis virus”Rev Sci Tech19:493-508.
Jacobs et al. 1988 “The thermal stability of oligonucleotide duplexes is sequence independent in tetraalkylammonium salt solutions: application to identifying recombinant DNA clones”Nucl Acids Res16:4637-4650.
Jalkanen et al. 1985 “Heparin sulfate proteoglycans from mouse mammary epithelial cells: localization on the cell surface witha monoclonal antibody”J Cell Biol101:976-984.
Jalkanen et al. 1987 “Cell surface proteoglycan of mouse mammary epithelial cells is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain”J Cell Biol.105:3087-3096.
Karpas et al. 1968 “Canine tracheobronchitis: isolation and characterization of the agent with experimental reproduction of the disease (32618)”Proc Soc Exp Biol Med127:45-52.
Keil and Fenwick 1998 “Role ofBordatella bronchisepticain infectious tracheobronchitis in dogs”J Am Vet Med Assoc212:200-207.
Lai and Cavanagh 1997 “The molecular Biology of Coronaviruses”Adv Vir Res48:4-22.
Lou and Wenner 1963 “Natural and experimental infection of dogs with reovirus, type 1: pathogenicity of the strain for other animals”Am J Hyg77:293-304.
Lu et al. 1981 “Improved synthesis of 4-alkoxybenzyl alcohol resin”J Org Chem46:3433-3436.
Luchansky et al. 1998 “Application of electroporation for transfer of plasmid DNA toLactobacillus, Lactococcus, Leuconostoc, Listeria, Pediococcus, Bacillus, Staphylococcus, EnterococcusandPropionibacterium” Mol Microbiol2:637-646.
Makela et al. 1998 “Viruses and bacteria in the etiology of the common cold”J Clin Microbiol36:539-542.
Morrison et al. 1984 “Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains”Proc Natl Acad Sci USA81:6851-6855.
National Office of Animal Health Ltd. (NOAH), Middlesex UK (2001), “Compendium of Data Sheets for Veterinary Products 2002-2003” pp. 216-217, 228-231, 322, 355-363, 448-449, 602-604, 700-706, 703-705 and 759-761.
Neuberger et al. 1988 8thInternational Biotechnology Symposium Part 2, pp. 792-799.
Page 1996 “TreeView: An applicat
Brownlie John
Chalker Victoria Jane
Erles Kerstin
Blumel Benjamin P
Knobbe Martens Olson & Bear LLP
Peng Bo
The Royal Veterinary College
LandOfFree
Canine respiratory coronavirus (CRCV) spike protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Canine respiratory coronavirus (CRCV) spike protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Canine respiratory coronavirus (CRCV) spike protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2733021